nodes	percent_of_prediction	percent_of_DWPC	metapath
Domperidone—ABCB1—lung cancer	0.165	1	CbGaD
Domperidone—CYP3A5—Gefitinib—lung cancer	0.0279	0.0435	CbGbCtD
Domperidone—CYP3A5—Teniposide—lung cancer	0.0271	0.0422	CbGbCtD
Domperidone—CYP3A7—Paclitaxel—lung cancer	0.0202	0.0314	CbGbCtD
Domperidone—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.0202	0.0314	CbGbCtD
Domperidone—CYP3A7—Irinotecan—lung cancer	0.0199	0.031	CbGbCtD
Domperidone—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.0199	0.031	CbGbCtD
Domperidone—ABCB1—Topotecan—lung cancer	0.0199	0.0309	CbGbCtD
Domperidone—CYP2B6—Irinotecan—lung cancer	0.0189	0.0295	CbGbCtD
Domperidone—ABCB1—Gefitinib—lung cancer	0.0182	0.0283	CbGbCtD
Domperidone—CYP2D6—Gefitinib—lung cancer	0.0171	0.0267	CbGbCtD
Domperidone—CYP3A5—Crizotinib—lung cancer	0.0171	0.0267	CbGbCtD
Domperidone—CYP3A5—Erlotinib—lung cancer	0.0165	0.0257	CbGbCtD
Domperidone—CYP2C8—Erlotinib—lung cancer	0.0159	0.0247	CbGbCtD
Domperidone—CYP2B6—Cisplatin—lung cancer	0.0154	0.024	CbGbCtD
Domperidone—CYP3A5—Paclitaxel—lung cancer	0.0151	0.0235	CbGbCtD
Domperidone—CYP3A5—Irinotecan—lung cancer	0.0149	0.0232	CbGbCtD
Domperidone—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.0146	0.0227	CbGbCtD
Domperidone—CYP3A7—Docetaxel—lung cancer	0.0146	0.0227	CbGbCtD
Domperidone—CYP2C8—Paclitaxel—lung cancer	0.0145	0.0226	CbGbCtD
Domperidone—ABCB1—Vinorelbine—lung cancer	0.014	0.0218	CbGbCtD
Domperidone—CYP2D6—Vinorelbine—lung cancer	0.0132	0.0205	CbGbCtD
Domperidone—CYP1A2—Erlotinib—lung cancer	0.0123	0.0191	CbGbCtD
Domperidone—CYP3A5—Etoposide—lung cancer	0.0119	0.0186	CbGbCtD
Domperidone—CYP3A4—Topotecan—lung cancer	0.0119	0.0185	CbGbCtD
Domperidone—CYP2C8—Etoposide—lung cancer	0.0115	0.0179	CbGbCtD
Domperidone—ABCB1—Crizotinib—lung cancer	0.0111	0.0173	CbGbCtD
Domperidone—CYP3A5—Docetaxel—lung cancer	0.0109	0.017	CbGbCtD
Domperidone—CYP3A4—Gefitinib—lung cancer	0.0109	0.017	CbGbCtD
Domperidone—ABCB1—Gemcitabine—lung cancer	0.0109	0.017	CbGbCtD
Domperidone—ABCB1—Erlotinib—lung cancer	0.0107	0.0167	CbGbCtD
Domperidone—CYP3A4—Teniposide—lung cancer	0.0106	0.0164	CbGbCtD
Domperidone—CYP2B6—Doxorubicin—lung cancer	0.0103	0.0161	CbGbCtD
Domperidone—CYP2D6—Erlotinib—lung cancer	0.0101	0.0158	CbGbCtD
Domperidone—ABCB1—Paclitaxel—lung cancer	0.00984	0.0153	CbGbCtD
Domperidone—ABCB1—Irinotecan—lung cancer	0.00971	0.0151	CbGbCtD
Domperidone—CYP1A2—Etoposide—lung cancer	0.00889	0.0138	CbGbCtD
Domperidone—ABCB1—Vinblastine—lung cancer	0.00863	0.0134	CbGbCtD
Domperidone—CYP3A4—Vinorelbine—lung cancer	0.00839	0.0131	CbGbCtD
Domperidone—CYP2D6—Vinblastine—lung cancer	0.00813	0.0127	CbGbCtD
Domperidone—ABCB1—Cisplatin—lung cancer	0.00791	0.0123	CbGbCtD
Domperidone—ABCB1—Etoposide—lung cancer	0.00777	0.0121	CbGbCtD
Domperidone—ABCB1—Docetaxel—lung cancer	0.00711	0.0111	CbGbCtD
Domperidone—CYP3A4—Crizotinib—lung cancer	0.00668	0.0104	CbGbCtD
Domperidone—CYP3A4—Erlotinib—lung cancer	0.00644	0.01	CbGbCtD
Domperidone—CYP3A4—Paclitaxel—lung cancer	0.00589	0.00918	CbGbCtD
Domperidone—CYP3A4—Irinotecan—lung cancer	0.00582	0.00905	CbGbCtD
Domperidone—ABCB1—Doxorubicin—lung cancer	0.0053	0.00825	CbGbCtD
Domperidone—CYP3A4—Vinblastine—lung cancer	0.00517	0.00805	CbGbCtD
Domperidone—ABCB1—Methotrexate—lung cancer	0.00514	0.008	CbGbCtD
Domperidone—CYP2D6—Doxorubicin—lung cancer	0.005	0.00778	CbGbCtD
Domperidone—CYP3A4—Etoposide—lung cancer	0.00466	0.00725	CbGbCtD
Domperidone—CYP3A4—Docetaxel—lung cancer	0.00426	0.00663	CbGbCtD
Domperidone—CYP3A4—Doxorubicin—lung cancer	0.00318	0.00495	CbGbCtD
Domperidone—Lethargy—Paclitaxel—lung cancer	0.000449	0.00483	CcSEcCtD
Domperidone—Asthenia—Gefitinib—lung cancer	0.000446	0.0048	CcSEcCtD
Domperidone—Pruritus—Pemetrexed—lung cancer	0.000443	0.00476	CcSEcCtD
Domperidone—Muscle spasms—Topotecan—lung cancer	0.000443	0.00476	CcSEcCtD
Domperidone—Pruritus—Gefitinib—lung cancer	0.00044	0.00473	CcSEcCtD
Domperidone—Vomiting—Crizotinib—lung cancer	0.000435	0.00469	CcSEcCtD
Domperidone—Rash—Crizotinib—lung cancer	0.000432	0.00465	CcSEcCtD
Domperidone—Dermatitis—Crizotinib—lung cancer	0.000431	0.00464	CcSEcCtD
Domperidone—Diarrhoea—Pemetrexed—lung cancer	0.000428	0.00461	CcSEcCtD
Domperidone—Diarrhoea—Gefitinib—lung cancer	0.000425	0.00458	CcSEcCtD
Domperidone—Dizziness—Pemetrexed—lung cancer	0.000414	0.00445	CcSEcCtD
Domperidone—Nausea—Crizotinib—lung cancer	0.000407	0.00438	CcSEcCtD
Domperidone—Stomatitis—Irinotecan—lung cancer	0.000405	0.00436	CcSEcCtD
Domperidone—Arrhythmia—Vinorelbine—lung cancer	0.000404	0.00435	CcSEcCtD
Domperidone—Urticaria—Teniposide—lung cancer	0.000403	0.00433	CcSEcCtD
Domperidone—Abdominal pain—Teniposide—lung cancer	0.000401	0.00431	CcSEcCtD
Domperidone—Hot flush—Docetaxel—lung cancer	0.000398	0.00429	CcSEcCtD
Domperidone—Vomiting—Pemetrexed—lung cancer	0.000398	0.00428	CcSEcCtD
Domperidone—Vomiting—Gefitinib—lung cancer	0.000395	0.00425	CcSEcCtD
Domperidone—Menopausal symptoms—Docetaxel—lung cancer	0.000395	0.00425	CcSEcCtD
Domperidone—Stomatitis—Gemcitabine—lung cancer	0.000395	0.00425	CcSEcCtD
Domperidone—Rash—Pemetrexed—lung cancer	0.000395	0.00425	CcSEcCtD
Domperidone—Dermatitis—Pemetrexed—lung cancer	0.000394	0.00424	CcSEcCtD
Domperidone—Rash—Gefitinib—lung cancer	0.000392	0.00422	CcSEcCtD
Domperidone—Dermatitis—Gefitinib—lung cancer	0.000392	0.00422	CcSEcCtD
Domperidone—Lethargy—Docetaxel—lung cancer	0.00038	0.00409	CcSEcCtD
Domperidone—Oedema—Erlotinib—lung cancer	0.000372	0.004	CcSEcCtD
Domperidone—Nausea—Pemetrexed—lung cancer	0.000372	0.004	CcSEcCtD
Domperidone—Nausea—Gefitinib—lung cancer	0.000369	0.00397	CcSEcCtD
Domperidone—Stomatitis—Cisplatin—lung cancer	0.000368	0.00396	CcSEcCtD
Domperidone—Breast pain—Doxorubicin—lung cancer	0.000367	0.00395	CcSEcCtD
Domperidone—Migraine—Docetaxel—lung cancer	0.000367	0.00395	CcSEcCtD
Domperidone—Conjunctivitis—Cisplatin—lung cancer	0.000367	0.00395	CcSEcCtD
Domperidone—Asthenia—Teniposide—lung cancer	0.000364	0.00391	CcSEcCtD
Domperidone—Pruritus—Teniposide—lung cancer	0.000359	0.00386	CcSEcCtD
Domperidone—Dysuria—Paclitaxel—lung cancer	0.000355	0.00383	CcSEcCtD
Domperidone—Pollakiuria—Paclitaxel—lung cancer	0.000351	0.00378	CcSEcCtD
Domperidone—Palpitations—Vinorelbine—lung cancer	0.000348	0.00374	CcSEcCtD
Domperidone—Diarrhoea—Teniposide—lung cancer	0.000347	0.00373	CcSEcCtD
Domperidone—Stomatitis—Etoposide—lung cancer	0.000337	0.00363	CcSEcCtD
Domperidone—Insomnia—Erlotinib—lung cancer	0.000336	0.00362	CcSEcCtD
Domperidone—Arrhythmia—Irinotecan—lung cancer	0.000333	0.00359	CcSEcCtD
Domperidone—Gynaecomastia—Methotrexate—lung cancer	0.000331	0.00356	CcSEcCtD
Domperidone—Constipation—Vinblastine—lung cancer	0.000331	0.00356	CcSEcCtD
Domperidone—Dyspepsia—Topotecan—lung cancer	0.000331	0.00356	CcSEcCtD
Domperidone—Stomatitis—Paclitaxel—lung cancer	0.00033	0.00356	CcSEcCtD
Domperidone—Conjunctivitis—Paclitaxel—lung cancer	0.000329	0.00355	CcSEcCtD
Domperidone—Dyspepsia—Erlotinib—lung cancer	0.000327	0.00352	CcSEcCtD
Domperidone—Arrhythmia—Gemcitabine—lung cancer	0.000325	0.00349	CcSEcCtD
Domperidone—Vomiting—Teniposide—lung cancer	0.000322	0.00347	CcSEcCtD
Domperidone—Constipation—Topotecan—lung cancer	0.000321	0.00346	CcSEcCtD
Domperidone—Rash—Teniposide—lung cancer	0.00032	0.00344	CcSEcCtD
Domperidone—Dermatitis—Teniposide—lung cancer	0.000319	0.00344	CcSEcCtD
Domperidone—Constipation—Erlotinib—lung cancer	0.000318	0.00342	CcSEcCtD
Domperidone—Headache—Teniposide—lung cancer	0.000318	0.00342	CcSEcCtD
Domperidone—Muscle spasms—Irinotecan—lung cancer	0.000312	0.00336	CcSEcCtD
Domperidone—Abdominal pain—Vinblastine—lung cancer	0.000306	0.00329	CcSEcCtD
Domperidone—Arrhythmia—Cisplatin—lung cancer	0.000303	0.00326	CcSEcCtD
Domperidone—Nausea—Teniposide—lung cancer	0.000301	0.00324	CcSEcCtD
Domperidone—Hypotension—Vinorelbine—lung cancer	0.0003	0.00323	CcSEcCtD
Domperidone—Urticaria—Topotecan—lung cancer	0.000298	0.00321	CcSEcCtD
Domperidone—Abdominal pain—Topotecan—lung cancer	0.000297	0.0032	CcSEcCtD
Domperidone—Cramps of lower extremities—Doxorubicin—lung cancer	0.000294	0.00317	CcSEcCtD
Domperidone—Abdominal pain—Erlotinib—lung cancer	0.000294	0.00316	CcSEcCtD
Domperidone—Muscle spasms—Cisplatin—lung cancer	0.000283	0.00305	CcSEcCtD
Domperidone—Stomatitis—Docetaxel—lung cancer	0.00028	0.00301	CcSEcCtD
Domperidone—Conjunctivitis—Docetaxel—lung cancer	0.000279	0.00301	CcSEcCtD
Domperidone—Asthenia—Vinblastine—lung cancer	0.000277	0.00299	CcSEcCtD
Domperidone—Constipation—Vinorelbine—lung cancer	0.000275	0.00296	CcSEcCtD
Domperidone—Lethargy—Methotrexate—lung cancer	0.000274	0.00295	CcSEcCtD
Domperidone—Arrhythmia—Paclitaxel—lung cancer	0.000272	0.00293	CcSEcCtD
Domperidone—Asthenia—Topotecan—lung cancer	0.00027	0.0029	CcSEcCtD
Domperidone—Asthenia—Erlotinib—lung cancer	0.000267	0.00287	CcSEcCtD
Domperidone—Pruritus—Topotecan—lung cancer	0.000266	0.00286	CcSEcCtD
Domperidone—Oedema—Irinotecan—lung cancer	0.000265	0.00285	CcSEcCtD
Domperidone—Diarrhoea—Vinblastine—lung cancer	0.000265	0.00285	CcSEcCtD
Domperidone—Pruritus—Erlotinib—lung cancer	0.000263	0.00283	CcSEcCtD
Domperidone—Tension—Paclitaxel—lung cancer	0.00026	0.0028	CcSEcCtD
Domperidone—Muscle spasms—Etoposide—lung cancer	0.00026	0.00279	CcSEcCtD
Domperidone—Oedema—Gemcitabine—lung cancer	0.000258	0.00278	CcSEcCtD
Domperidone—Nervousness—Paclitaxel—lung cancer	0.000257	0.00277	CcSEcCtD
Domperidone—Diarrhoea—Topotecan—lung cancer	0.000257	0.00277	CcSEcCtD
Domperidone—Irritability—Methotrexate—lung cancer	0.000256	0.00276	CcSEcCtD
Domperidone—Dizziness—Vinblastine—lung cancer	0.000256	0.00275	CcSEcCtD
Domperidone—Urticaria—Vinorelbine—lung cancer	0.000255	0.00275	CcSEcCtD
Domperidone—Muscle spasms—Paclitaxel—lung cancer	0.000255	0.00274	CcSEcCtD
Domperidone—Diarrhoea—Erlotinib—lung cancer	0.000254	0.00274	CcSEcCtD
Domperidone—Abdominal pain—Vinorelbine—lung cancer	0.000254	0.00273	CcSEcCtD
Domperidone—Hot flush—Doxorubicin—lung cancer	0.000249	0.00268	CcSEcCtD
Domperidone—Dizziness—Topotecan—lung cancer	0.000248	0.00267	CcSEcCtD
Domperidone—Hypotension—Irinotecan—lung cancer	0.000248	0.00267	CcSEcCtD
Domperidone—Menopausal symptoms—Doxorubicin—lung cancer	0.000247	0.00265	CcSEcCtD
Domperidone—Vomiting—Vinblastine—lung cancer	0.000246	0.00265	CcSEcCtD
Domperidone—Dizziness—Erlotinib—lung cancer	0.000246	0.00265	CcSEcCtD
Domperidone—Headache—Vinblastine—lung cancer	0.000242	0.00261	CcSEcCtD
Domperidone—Hypotension—Gemcitabine—lung cancer	0.000241	0.0026	CcSEcCtD
Domperidone—Oedema—Cisplatin—lung cancer	0.000241	0.00259	CcSEcCtD
Domperidone—Insomnia—Irinotecan—lung cancer	0.00024	0.00258	CcSEcCtD
Domperidone—Vomiting—Topotecan—lung cancer	0.000239	0.00257	CcSEcCtD
Domperidone—Lethargy—Doxorubicin—lung cancer	0.000237	0.00255	CcSEcCtD
Domperidone—Rash—Topotecan—lung cancer	0.000237	0.00255	CcSEcCtD
Domperidone—Dermatitis—Topotecan—lung cancer	0.000237	0.00255	CcSEcCtD
Domperidone—Vomiting—Erlotinib—lung cancer	0.000236	0.00254	CcSEcCtD
Domperidone—Somnolence—Irinotecan—lung cancer	0.000236	0.00254	CcSEcCtD
Domperidone—Headache—Topotecan—lung cancer	0.000235	0.00253	CcSEcCtD
Domperidone—Rash—Erlotinib—lung cancer	0.000234	0.00252	CcSEcCtD
Domperidone—Dermatitis—Erlotinib—lung cancer	0.000234	0.00252	CcSEcCtD
Domperidone—Palpitations—Paclitaxel—lung cancer	0.000234	0.00252	CcSEcCtD
Domperidone—Insomnia—Gemcitabine—lung cancer	0.000234	0.00251	CcSEcCtD
Domperidone—Dyspepsia—Irinotecan—lung cancer	0.000233	0.00251	CcSEcCtD
Domperidone—Headache—Erlotinib—lung cancer	0.000233	0.00251	CcSEcCtD
Domperidone—Asthenia—Vinorelbine—lung cancer	0.000231	0.00248	CcSEcCtD
Domperidone—Arrhythmia—Docetaxel—lung cancer	0.00023	0.00248	CcSEcCtD
Domperidone—Nausea—Vinblastine—lung cancer	0.00023	0.00247	CcSEcCtD
Domperidone—Somnolence—Gemcitabine—lung cancer	0.00023	0.00247	CcSEcCtD
Domperidone—Migraine—Doxorubicin—lung cancer	0.000229	0.00246	CcSEcCtD
Domperidone—Pruritus—Vinorelbine—lung cancer	0.000227	0.00245	CcSEcCtD
Domperidone—Constipation—Irinotecan—lung cancer	0.000227	0.00244	CcSEcCtD
Domperidone—Hypotension—Cisplatin—lung cancer	0.000225	0.00242	CcSEcCtD
Domperidone—Nausea—Topotecan—lung cancer	0.000223	0.0024	CcSEcCtD
Domperidone—Constipation—Gemcitabine—lung cancer	0.000221	0.00238	CcSEcCtD
Domperidone—Nausea—Erlotinib—lung cancer	0.000221	0.00238	CcSEcCtD
Domperidone—Dry mouth—Paclitaxel—lung cancer	0.000221	0.00237	CcSEcCtD
Domperidone—Diarrhoea—Vinorelbine—lung cancer	0.00022	0.00237	CcSEcCtD
Domperidone—Dysuria—Methotrexate—lung cancer	0.000217	0.00234	CcSEcCtD
Domperidone—Oedema—Paclitaxel—lung cancer	0.000216	0.00233	CcSEcCtD
Domperidone—Muscle spasms—Docetaxel—lung cancer	0.000216	0.00232	CcSEcCtD
Domperidone—Dizziness—Vinorelbine—lung cancer	0.000213	0.00229	CcSEcCtD
Domperidone—Abdominal pain—Irinotecan—lung cancer	0.00021	0.00225	CcSEcCtD
Domperidone—Drowsiness—Methotrexate—lung cancer	0.000207	0.00223	CcSEcCtD
Domperidone—Hypotension—Etoposide—lung cancer	0.000206	0.00222	CcSEcCtD
Domperidone—Vomiting—Vinorelbine—lung cancer	0.000204	0.0022	CcSEcCtD
Domperidone—Rash—Vinorelbine—lung cancer	0.000203	0.00218	CcSEcCtD
Domperidone—Dermatitis—Vinorelbine—lung cancer	0.000202	0.00218	CcSEcCtD
Domperidone—Hypotension—Paclitaxel—lung cancer	0.000202	0.00217	CcSEcCtD
Domperidone—Stomatitis—Methotrexate—lung cancer	0.000202	0.00217	CcSEcCtD
Domperidone—Headache—Vinorelbine—lung cancer	0.000201	0.00217	CcSEcCtD
Domperidone—Conjunctivitis—Methotrexate—lung cancer	0.000201	0.00217	CcSEcCtD
Domperidone—Palpitations—Docetaxel—lung cancer	0.000198	0.00214	CcSEcCtD
Domperidone—Somnolence—Etoposide—lung cancer	0.000196	0.00211	CcSEcCtD
Domperidone—Insomnia—Paclitaxel—lung cancer	0.000196	0.0021	CcSEcCtD
Domperidone—Somnolence—Paclitaxel—lung cancer	0.000192	0.00207	CcSEcCtD
Domperidone—Nausea—Vinorelbine—lung cancer	0.000191	0.00205	CcSEcCtD
Domperidone—Dyspepsia—Paclitaxel—lung cancer	0.00019	0.00205	CcSEcCtD
Domperidone—Asthenia—Irinotecan—lung cancer	0.00019	0.00205	CcSEcCtD
Domperidone—Constipation—Etoposide—lung cancer	0.000189	0.00203	CcSEcCtD
Domperidone—Dysuria—Doxorubicin—lung cancer	0.000188	0.00202	CcSEcCtD
Domperidone—Dry mouth—Docetaxel—lung cancer	0.000187	0.00201	CcSEcCtD
Domperidone—Pollakiuria—Doxorubicin—lung cancer	0.000186	0.002	CcSEcCtD
Domperidone—Asthenia—Gemcitabine—lung cancer	0.000185	0.00199	CcSEcCtD
Domperidone—Constipation—Paclitaxel—lung cancer	0.000185	0.00199	CcSEcCtD
Domperidone—Oedema—Docetaxel—lung cancer	0.000183	0.00197	CcSEcCtD
Domperidone—Pruritus—Gemcitabine—lung cancer	0.000183	0.00197	CcSEcCtD
Domperidone—Diarrhoea—Irinotecan—lung cancer	0.000181	0.00195	CcSEcCtD
Domperidone—Drowsiness—Doxorubicin—lung cancer	0.000179	0.00193	CcSEcCtD
Domperidone—Diarrhoea—Gemcitabine—lung cancer	0.000177	0.0019	CcSEcCtD
Domperidone—Dizziness—Irinotecan—lung cancer	0.000175	0.00189	CcSEcCtD
Domperidone—Urticaria—Etoposide—lung cancer	0.000175	0.00188	CcSEcCtD
Domperidone—Stomatitis—Doxorubicin—lung cancer	0.000175	0.00188	CcSEcCtD
Domperidone—Abdominal pain—Etoposide—lung cancer	0.000174	0.00188	CcSEcCtD
Domperidone—Conjunctivitis—Doxorubicin—lung cancer	0.000174	0.00188	CcSEcCtD
Domperidone—Asthenia—Cisplatin—lung cancer	0.000173	0.00186	CcSEcCtD
Domperidone—Urticaria—Paclitaxel—lung cancer	0.000172	0.00185	CcSEcCtD
Domperidone—Hypotension—Docetaxel—lung cancer	0.000171	0.00184	CcSEcCtD
Domperidone—Abdominal pain—Paclitaxel—lung cancer	0.000171	0.00184	CcSEcCtD
Domperidone—Vomiting—Irinotecan—lung cancer	0.000169	0.00181	CcSEcCtD
Domperidone—Rash—Irinotecan—lung cancer	0.000167	0.0018	CcSEcCtD
Domperidone—Dermatitis—Irinotecan—lung cancer	0.000167	0.0018	CcSEcCtD
Domperidone—Headache—Irinotecan—lung cancer	0.000166	0.00179	CcSEcCtD
Domperidone—Insomnia—Docetaxel—lung cancer	0.000166	0.00178	CcSEcCtD
Domperidone—Diarrhoea—Cisplatin—lung cancer	0.000165	0.00177	CcSEcCtD
Domperidone—Vomiting—Gemcitabine—lung cancer	0.000164	0.00177	CcSEcCtD
Domperidone—Somnolence—Docetaxel—lung cancer	0.000163	0.00175	CcSEcCtD
Domperidone—Rash—Gemcitabine—lung cancer	0.000163	0.00175	CcSEcCtD
Domperidone—Dermatitis—Gemcitabine—lung cancer	0.000163	0.00175	CcSEcCtD
Domperidone—Headache—Gemcitabine—lung cancer	0.000162	0.00174	CcSEcCtD
Domperidone—Dyspepsia—Docetaxel—lung cancer	0.000161	0.00174	CcSEcCtD
Domperidone—Asthenia—Etoposide—lung cancer	0.000158	0.0017	CcSEcCtD
Domperidone—Nausea—Irinotecan—lung cancer	0.000157	0.00169	CcSEcCtD
Domperidone—Constipation—Docetaxel—lung cancer	0.000157	0.00169	CcSEcCtD
Domperidone—Pruritus—Etoposide—lung cancer	0.000156	0.00168	CcSEcCtD
Domperidone—Asthenia—Paclitaxel—lung cancer	0.000155	0.00167	CcSEcCtD
Domperidone—Nausea—Gemcitabine—lung cancer	0.000153	0.00165	CcSEcCtD
Domperidone—Vomiting—Cisplatin—lung cancer	0.000153	0.00165	CcSEcCtD
Domperidone—Pruritus—Paclitaxel—lung cancer	0.000153	0.00165	CcSEcCtD
Domperidone—Rash—Cisplatin—lung cancer	0.000152	0.00163	CcSEcCtD
Domperidone—Dermatitis—Cisplatin—lung cancer	0.000152	0.00163	CcSEcCtD
Domperidone—Diarrhoea—Etoposide—lung cancer	0.000151	0.00162	CcSEcCtD
Domperidone—Diarrhoea—Paclitaxel—lung cancer	0.000148	0.00159	CcSEcCtD
Domperidone—Dizziness—Etoposide—lung cancer	0.000146	0.00157	CcSEcCtD
Domperidone—Abdominal pain—Docetaxel—lung cancer	0.000145	0.00156	CcSEcCtD
Domperidone—Arrhythmia—Doxorubicin—lung cancer	0.000144	0.00155	CcSEcCtD
Domperidone—Dizziness—Paclitaxel—lung cancer	0.000143	0.00154	CcSEcCtD
Domperidone—Nausea—Cisplatin—lung cancer	0.000143	0.00154	CcSEcCtD
Domperidone—Vomiting—Etoposide—lung cancer	0.00014	0.00151	CcSEcCtD
Domperidone—Rash—Etoposide—lung cancer	0.000139	0.0015	CcSEcCtD
Domperidone—Dermatitis—Etoposide—lung cancer	0.000139	0.00149	CcSEcCtD
Domperidone—Headache—Etoposide—lung cancer	0.000138	0.00149	CcSEcCtD
Domperidone—Tension—Doxorubicin—lung cancer	0.000137	0.00148	CcSEcCtD
Domperidone—Vomiting—Paclitaxel—lung cancer	0.000137	0.00148	CcSEcCtD
Domperidone—Rash—Paclitaxel—lung cancer	0.000136	0.00147	CcSEcCtD
Domperidone—Dermatitis—Paclitaxel—lung cancer	0.000136	0.00147	CcSEcCtD
Domperidone—Nervousness—Doxorubicin—lung cancer	0.000136	0.00146	CcSEcCtD
Domperidone—Headache—Paclitaxel—lung cancer	0.000135	0.00146	CcSEcCtD
Domperidone—Muscle spasms—Doxorubicin—lung cancer	0.000135	0.00145	CcSEcCtD
Domperidone—Asthenia—Docetaxel—lung cancer	0.000131	0.00141	CcSEcCtD
Domperidone—Nausea—Etoposide—lung cancer	0.000131	0.00141	CcSEcCtD
Domperidone—Pruritus—Docetaxel—lung cancer	0.00013	0.0014	CcSEcCtD
Domperidone—Nausea—Paclitaxel—lung cancer	0.000128	0.00138	CcSEcCtD
Domperidone—Diarrhoea—Docetaxel—lung cancer	0.000125	0.00135	CcSEcCtD
Domperidone—Palpitations—Doxorubicin—lung cancer	0.000124	0.00133	CcSEcCtD
Domperidone—Hypotension—Methotrexate—lung cancer	0.000123	0.00133	CcSEcCtD
Domperidone—Pimozide—CYP2E1—lung cancer	0.000122	0.333	CrCbGaD
Domperidone—Dizziness—Docetaxel—lung cancer	0.000121	0.0013	CcSEcCtD
Domperidone—Insomnia—Methotrexate—lung cancer	0.000119	0.00129	CcSEcCtD
Domperidone—Somnolence—Methotrexate—lung cancer	0.000117	0.00126	CcSEcCtD
Domperidone—Dry mouth—Doxorubicin—lung cancer	0.000117	0.00126	CcSEcCtD
Domperidone—Vomiting—Docetaxel—lung cancer	0.000116	0.00125	CcSEcCtD
Domperidone—Dyspepsia—Methotrexate—lung cancer	0.000116	0.00125	CcSEcCtD
Domperidone—Rash—Docetaxel—lung cancer	0.000116	0.00124	CcSEcCtD
Domperidone—Dermatitis—Docetaxel—lung cancer	0.000115	0.00124	CcSEcCtD
Domperidone—Headache—Docetaxel—lung cancer	0.000115	0.00124	CcSEcCtD
Domperidone—Oedema—Doxorubicin—lung cancer	0.000114	0.00123	CcSEcCtD
Domperidone—Nausea—Docetaxel—lung cancer	0.000109	0.00117	CcSEcCtD
Domperidone—Hypotension—Doxorubicin—lung cancer	0.000107	0.00115	CcSEcCtD
Domperidone—Urticaria—Methotrexate—lung cancer	0.000105	0.00113	CcSEcCtD
Domperidone—Abdominal pain—Methotrexate—lung cancer	0.000104	0.00112	CcSEcCtD
Domperidone—Insomnia—Doxorubicin—lung cancer	0.000103	0.00111	CcSEcCtD
Domperidone—Somnolence—Doxorubicin—lung cancer	0.000102	0.00109	CcSEcCtD
Domperidone—Dyspepsia—Doxorubicin—lung cancer	0.000101	0.00108	CcSEcCtD
Domperidone—Constipation—Doxorubicin—lung cancer	9.78e-05	0.00105	CcSEcCtD
Domperidone—Asthenia—Methotrexate—lung cancer	9.47e-05	0.00102	CcSEcCtD
Domperidone—Pruritus—Methotrexate—lung cancer	9.34e-05	0.00101	CcSEcCtD
Domperidone—Urticaria—Doxorubicin—lung cancer	9.08e-05	0.000978	CcSEcCtD
Domperidone—Abdominal pain—Doxorubicin—lung cancer	9.04e-05	0.000973	CcSEcCtD
Domperidone—Diarrhoea—Methotrexate—lung cancer	9.04e-05	0.000972	CcSEcCtD
Domperidone—Dizziness—Methotrexate—lung cancer	8.73e-05	0.00094	CcSEcCtD
Domperidone—Vomiting—Methotrexate—lung cancer	8.4e-05	0.000904	CcSEcCtD
Domperidone—Rash—Methotrexate—lung cancer	8.33e-05	0.000896	CcSEcCtD
Domperidone—Dermatitis—Methotrexate—lung cancer	8.32e-05	0.000895	CcSEcCtD
Domperidone—Headache—Methotrexate—lung cancer	8.27e-05	0.00089	CcSEcCtD
Domperidone—Asthenia—Doxorubicin—lung cancer	8.2e-05	0.000883	CcSEcCtD
Domperidone—Pruritus—Doxorubicin—lung cancer	8.09e-05	0.000871	CcSEcCtD
Domperidone—Nausea—Methotrexate—lung cancer	7.84e-05	0.000844	CcSEcCtD
Domperidone—Diarrhoea—Doxorubicin—lung cancer	7.82e-05	0.000842	CcSEcCtD
Domperidone—Dizziness—Doxorubicin—lung cancer	7.56e-05	0.000814	CcSEcCtD
Domperidone—Vomiting—Doxorubicin—lung cancer	7.27e-05	0.000782	CcSEcCtD
Domperidone—Rash—Doxorubicin—lung cancer	7.21e-05	0.000776	CcSEcCtD
Domperidone—Dermatitis—Doxorubicin—lung cancer	7.2e-05	0.000775	CcSEcCtD
Domperidone—Headache—Doxorubicin—lung cancer	7.16e-05	0.000771	CcSEcCtD
Domperidone—Nausea—Doxorubicin—lung cancer	6.79e-05	0.000731	CcSEcCtD
Domperidone—Pimozide—ABCB1—lung cancer	6.4e-05	0.175	CrCbGaD
Domperidone—Nefazodone—ABCB1—lung cancer	6.37e-05	0.174	CrCbGaD
Domperidone—Trazodone—ABCB1—lung cancer	5.89e-05	0.161	CrCbGaD
Domperidone—Pipotiazine—ALB—lung cancer	5.78e-05	0.158	CrCbGaD
Domperidone—CYP2D6—Metabolism—NQO1—lung cancer	6.92e-06	6.95e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IL6R—lung cancer	6.85e-06	6.88e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CAT—lung cancer	6.84e-06	6.87e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CREBBP—lung cancer	6.84e-06	6.87e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.8e-06	6.83e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—AKR1C1—lung cancer	6.8e-06	6.83e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PIK3CD—lung cancer	6.73e-06	6.77e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—IL2—lung cancer	6.72e-06	6.76e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—EGFR—lung cancer	6.72e-06	6.75e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TERT—lung cancer	6.7e-06	6.73e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—ABCB1—lung cancer	6.65e-06	6.68e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—ALB—lung cancer	6.65e-06	6.68e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—STK11—lung cancer	6.62e-06	6.65e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ENO1—lung cancer	6.61e-06	6.64e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—UGT1A1—lung cancer	6.6e-06	6.63e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	6.58e-06	6.62e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—TYMS—lung cancer	6.53e-06	6.56e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MAP2K1—lung cancer	6.53e-06	6.56e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—FGFR1—lung cancer	6.5e-06	6.54e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	6.5e-06	6.53e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PIK3CD—lung cancer	6.48e-06	6.51e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—GSTM1—lung cancer	6.46e-06	6.49e-05	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—PIK3CA—lung cancer	6.42e-06	6.45e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—HIF1A—lung cancer	6.41e-06	6.44e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GNG11—lung cancer	6.36e-06	6.39e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—KRAS—lung cancer	6.35e-06	6.38e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—STK11—lung cancer	6.24e-06	6.27e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—APOA1—lung cancer	6.2e-06	6.23e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—APOA1—lung cancer	6.18e-06	6.21e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—KDR—lung cancer	6.13e-06	6.16e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GSTP1—lung cancer	6.12e-06	6.15e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CYP1A1—lung cancer	6.12e-06	6.15e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—ERCC2—lung cancer	6.07e-06	6.1e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—APOA1—lung cancer	6.06e-06	6.09e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ALDOA—lung cancer	6.06e-06	6.09e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CAT—lung cancer	5.96e-06	5.99e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CYP2E1—lung cancer	5.93e-06	5.96e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—NCOA3—lung cancer	5.88e-06	5.91e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PIK3CB—lung cancer	5.87e-06	5.9e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—NQO1—lung cancer	5.86e-06	5.89e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—PIK3CA—lung cancer	5.83e-06	5.86e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PTGS2—lung cancer	5.82e-06	5.84e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MDM2—lung cancer	5.81e-06	5.84e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—RAF1—lung cancer	5.79e-06	5.82e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GSTP1—lung cancer	5.77e-06	5.8e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.74e-06	5.77e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—ERBB2—lung cancer	5.73e-06	5.75e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ABCG2—lung cancer	5.72e-06	5.75e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ADCY1—lung cancer	5.72e-06	5.75e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—TYMS—lung cancer	5.69e-06	5.72e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.69e-06	5.71e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PIK3CG—lung cancer	5.66e-06	5.69e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PIK3CB—lung cancer	5.65e-06	5.68e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MTOR—lung cancer	5.65e-06	5.68e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PIK3CG—lung cancer	5.64e-06	5.67e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—KIT—lung cancer	5.64e-06	5.67e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—APC—lung cancer	5.64e-06	5.67e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—NRAS—lung cancer	5.64e-06	5.67e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GSTM1—lung cancer	5.63e-06	5.65e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CAT—lung cancer	5.61e-06	5.64e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—HPGDS—lung cancer	5.61e-06	5.64e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ENO2—lung cancer	5.61e-06	5.64e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—EGF—lung cancer	5.58e-06	5.61e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PPP2R1B—lung cancer	5.58e-06	5.6e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PIK3CG—lung cancer	5.54e-06	5.56e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—ABCB1—lung cancer	5.46e-06	5.49e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GSTT1—lung cancer	5.44e-06	5.47e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CXCL8—lung cancer	5.43e-06	5.46e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—MAPK3—lung cancer	5.4e-06	5.43e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—HRAS—lung cancer	5.4e-06	5.42e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—POMC—lung cancer	5.39e-06	5.42e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP2A6—lung cancer	5.38e-06	5.41e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GCLC—lung cancer	5.38e-06	5.41e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—POMC—lung cancer	5.37e-06	5.4e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—TYMS—lung cancer	5.36e-06	5.39e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CYP1A1—lung cancer	5.33e-06	5.36e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—BRAF—lung cancer	5.3e-06	5.33e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GSTM1—lung cancer	5.3e-06	5.33e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—ERCC2—lung cancer	5.29e-06	5.32e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—STK11—lung cancer	5.28e-06	5.31e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—POMC—lung cancer	5.27e-06	5.3e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—APOA1—lung cancer	5.25e-06	5.28e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—CREBBP—lung cancer	5.25e-06	5.28e-05	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—AKT1—lung cancer	5.25e-06	5.27e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IL6R—lung cancer	5.24e-06	5.27e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CREBBP—lung cancer	5.23e-06	5.26e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CASP3—lung cancer	5.2e-06	5.22e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IL2—lung cancer	5.19e-06	5.21e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—IL6—lung cancer	5.16e-06	5.19e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—EGFR—lung cancer	5.14e-06	5.17e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—CREBBP—lung cancer	5.13e-06	5.16e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ENO1—lung cancer	5.1e-06	5.12e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PTEN—lung cancer	5.07e-06	5.1e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CCND1—lung cancer	5.06e-06	5.08e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—JUN—lung cancer	5.05e-06	5.07e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.03e-06	5.05e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CYP1A1—lung cancer	5.03e-06	5.05e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MAP2K1—lung cancer	4.99e-06	5.02e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—ERCC2—lung cancer	4.98e-06	5.01e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PIK3CD—lung cancer	4.98e-06	5e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PIK3CD—lung cancer	4.96e-06	4.98e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.96e-06	4.98e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—ALB—lung cancer	4.92e-06	4.94e-05	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—PIK3CA—lung cancer	4.91e-06	4.94e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MMP9—lung cancer	4.91e-06	4.94e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CDKN1A—lung cancer	4.89e-06	4.92e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GSTP1—lung cancer	4.89e-06	4.91e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PTEN—lung cancer	4.88e-06	4.91e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PIK3CD—lung cancer	4.87e-06	4.89e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—KRAS—lung cancer	4.86e-06	4.88e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—EP300—lung cancer	4.84e-06	4.86e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—ALB—lung cancer	4.8e-06	4.83e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PIK3CG—lung cancer	4.8e-06	4.82e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—AKT1—lung cancer	4.76e-06	4.79e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CAT—lung cancer	4.76e-06	4.78e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.73e-06	4.75e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—EP300—lung cancer	4.66e-06	4.68e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ABCB1—lung cancer	4.63e-06	4.65e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—APOA1—lung cancer	4.58e-06	4.6e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP2E1—lung cancer	4.57e-06	4.6e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—POMC—lung cancer	4.56e-06	4.59e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—TYMS—lung cancer	4.54e-06	4.57e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—SRC—lung cancer	4.53e-06	4.55e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—NQO1—lung cancer	4.52e-06	4.54e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GSTM1—lung cancer	4.49e-06	4.51e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—PIK3CA—lung cancer	4.46e-06	4.48e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CREBBP—lung cancer	4.45e-06	4.47e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MDM2—lung cancer	4.44e-06	4.47e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—RAF1—lung cancer	4.43e-06	4.45e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—VEGFA—lung cancer	4.41e-06	4.43e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—ERBB2—lung cancer	4.38e-06	4.4e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—STAT3—lung cancer	4.37e-06	4.39e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—NRAS—lung cancer	4.36e-06	4.38e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PIK3CB—lung cancer	4.34e-06	4.36e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PIK3CB—lung cancer	4.32e-06	4.35e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MTOR—lung cancer	4.32e-06	4.35e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—APOA1—lung cancer	4.31e-06	4.33e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PTGS2—lung cancer	4.3e-06	4.32e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CYP1A1—lung cancer	4.26e-06	4.28e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PIK3CB—lung cancer	4.24e-06	4.26e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ERCC2—lung cancer	4.22e-06	4.24e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PIK3CD—lung cancer	4.22e-06	4.24e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PTGS2—lung cancer	4.2e-06	4.22e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PIK3CG—lung cancer	4.18e-06	4.2e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MAPK3—lung cancer	4.17e-06	4.19e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—ALB—lung cancer	4.16e-06	4.18e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CXCL8—lung cancer	4.16e-06	4.18e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—HRAS—lung cancer	4.13e-06	4.15e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—STK11—lung cancer	4.08e-06	4.1e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MYC—lung cancer	4.06e-06	4.08e-05	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—AKT1—lung cancer	4.01e-06	4.03e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CASP3—lung cancer	3.98e-06	4e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—POMC—lung cancer	3.98e-06	4e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IL2—lung cancer	3.97e-06	3.99e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—EGFR—lung cancer	3.97e-06	3.99e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—IL6—lung cancer	3.95e-06	3.97e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PIK3CG—lung cancer	3.94e-06	3.96e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CREBBP—lung cancer	3.87e-06	3.89e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CCND1—lung cancer	3.87e-06	3.89e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—JUN—lung cancer	3.86e-06	3.88e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GSTP1—lung cancer	3.77e-06	3.79e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MMP9—lung cancer	3.76e-06	3.78e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PTEN—lung cancer	3.75e-06	3.77e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—KRAS—lung cancer	3.75e-06	3.77e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—POMC—lung cancer	3.75e-06	3.77e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CDKN1A—lung cancer	3.75e-06	3.76e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PTEN—lung cancer	3.74e-06	3.75e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PIK3CB—lung cancer	3.67e-06	3.69e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PIK3CD—lung cancer	3.67e-06	3.69e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CAT—lung cancer	3.67e-06	3.69e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PTEN—lung cancer	3.67e-06	3.68e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—APOA1—lung cancer	3.65e-06	3.67e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CREBBP—lung cancer	3.65e-06	3.67e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—AKT1—lung cancer	3.65e-06	3.66e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PTGS2—lung cancer	3.64e-06	3.66e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—ALB—lung cancer	3.63e-06	3.64e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PIK3CA—lung cancer	3.58e-06	3.59e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—EP300—lung cancer	3.58e-06	3.59e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ABCB1—lung cancer	3.57e-06	3.59e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—EP300—lung cancer	3.56e-06	3.58e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—TYMS—lung cancer	3.51e-06	3.52e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.5e-06	3.51e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—EP300—lung cancer	3.5e-06	3.51e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GSTM1—lung cancer	3.47e-06	3.48e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—SRC—lung cancer	3.47e-06	3.48e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PIK3CD—lung cancer	3.46e-06	3.48e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PIK3CA—lung cancer	3.45e-06	3.46e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—ALB—lung cancer	3.42e-06	3.43e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—VEGFA—lung cancer	3.38e-06	3.39e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—STAT3—lung cancer	3.34e-06	3.36e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PIK3CG—lung cancer	3.34e-06	3.35e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—NRAS—lung cancer	3.33e-06	3.35e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—TP53—lung cancer	3.33e-06	3.35e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP1A1—lung cancer	3.29e-06	3.3e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ERCC2—lung cancer	3.26e-06	3.27e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PIK3CB—lung cancer	3.2e-06	3.22e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MAPK3—lung cancer	3.19e-06	3.21e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—HRAS—lung cancer	3.19e-06	3.2e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PTEN—lung cancer	3.18e-06	3.19e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—POMC—lung cancer	3.17e-06	3.19e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PTGS2—lung cancer	3.17e-06	3.19e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MYC—lung cancer	3.11e-06	3.12e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CREBBP—lung cancer	3.09e-06	3.11e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IL6—lung cancer	3.05e-06	3.07e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—EGFR—lung cancer	3.04e-06	3.05e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—EP300—lung cancer	3.03e-06	3.04e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PIK3CB—lung cancer	3.02e-06	3.03e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PTGS2—lung cancer	2.99e-06	3e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PIK3CD—lung cancer	2.93e-06	2.95e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—AKT1—lung cancer	2.92e-06	2.94e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ALB—lung cancer	2.89e-06	2.91e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—KRAS—lung cancer	2.87e-06	2.88e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—APOA1—lung cancer	2.82e-06	2.83e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—AKT1—lung cancer	2.81e-06	2.83e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PTEN—lung cancer	2.77e-06	2.78e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PIK3CA—lung cancer	2.65e-06	2.66e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—EP300—lung cancer	2.64e-06	2.65e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PIK3CA—lung cancer	2.64e-06	2.65e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PTEN—lung cancer	2.61e-06	2.62e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PIK3CA—lung cancer	2.59e-06	2.6e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PIK3CG—lung cancer	2.57e-06	2.59e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PIK3CB—lung cancer	2.56e-06	2.57e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TP53—lung cancer	2.55e-06	2.56e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PTGS2—lung cancer	2.53e-06	2.54e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—EP300—lung cancer	2.49e-06	2.5e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—POMC—lung cancer	2.45e-06	2.46e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—HRAS—lung cancer	2.44e-06	2.45e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CREBBP—lung cancer	2.39e-06	2.4e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IL6—lung cancer	2.33e-06	2.35e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PIK3CD—lung cancer	2.26e-06	2.27e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PIK3CA—lung cancer	2.24e-06	2.25e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ALB—lung cancer	2.23e-06	2.24e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PTEN—lung cancer	2.21e-06	2.22e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—AKT1—lung cancer	2.16e-06	2.17e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—AKT1—lung cancer	2.15e-06	2.16e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—AKT1—lung cancer	2.11e-06	2.12e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—EP300—lung cancer	2.11e-06	2.12e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PIK3CB—lung cancer	1.97e-06	1.98e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PTGS2—lung cancer	1.95e-06	1.96e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PIK3CA—lung cancer	1.95e-06	1.96e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PIK3CA—lung cancer	1.84e-06	1.85e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—AKT1—lung cancer	1.83e-06	1.84e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PTEN—lung cancer	1.7e-06	1.71e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—EP300—lung cancer	1.63e-06	1.63e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—AKT1—lung cancer	1.59e-06	1.6e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PIK3CA—lung cancer	1.56e-06	1.57e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—AKT1—lung cancer	1.5e-06	1.51e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—AKT1—lung cancer	1.27e-06	1.28e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PIK3CA—lung cancer	1.2e-06	1.21e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—AKT1—lung cancer	9.82e-07	9.87e-06	CbGpPWpGaD
